» Articles » PMID: 34884466

Implications of Gut Microbiota in Complex Human Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Dec 10
PMID 34884466
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Humans, throughout the life cycle, from birth to death, are accompanied by the presence of gut microbes. Environmental factors, lifestyle, age and other factors can affect the balance of intestinal microbiota and their impact on human health. A large amount of data show that dietary, prebiotics, antibiotics can regulate various diseases through gut microbes. In this review, we focus on the role of gut microbes in the development of metabolic, gastrointestinal, neurological, immune diseases and, cancer. We also discuss the interaction between gut microbes and the host with respect to their beneficial and harmful effects, including their metabolites, microbial enzymes, small molecules and inflammatory molecules. More specifically, we evaluate the potential ability of gut microbes to cure diseases through Fecal Microbial Transplantation (FMT), which is expected to become a new type of clinical strategy for the treatment of various diseases.

Citing Articles

Metagenomic analysis reveals the community composition of the microbiome in different segments of the digestive tract in donkeys and cows: implications for microbiome research.

Su L, Guo J, Shi W, Tong W, Li X, Yang B BMC Microbiol. 2024; 24(1):530.

PMID: 39695983 PMC: 11656932. DOI: 10.1186/s12866-024-03696-5.


Gut microbiota in health and disease: advances and future prospects.

Zhang Y, Wang H, Sang Y, Liu M, Wang Q, Yang H MedComm (2020). 2024; 5(12):e70012.

PMID: 39568773 PMC: 11577303. DOI: 10.1002/mco2.70012.


Exploring the Effect of Gastrointestinal on Growth Performance Traits in Livestock Animals.

Kou X, Ma Q, Liu Y, Khan M, Wu B, Chen W Animals (Basel). 2024; 14(13).

PMID: 38998077 PMC: 11240335. DOI: 10.3390/ani14131965.


Phenylthiazoles with potent & optimum selectivity toward .

Seif El-Din M, Hagras M, Mayhoub A RSC Med Chem. 2024; 15(6):1991-2001.

PMID: 38911156 PMC: 11187570. DOI: 10.1039/d4md00164h.


Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.

Luqman A, Hassan A, Ullah M, Naseem S, Ullah M, Zhang L Front Immunol. 2024; 15:1321395.

PMID: 38343539 PMC: 10853344. DOI: 10.3389/fimmu.2024.1321395.


References
1.
Roediger W, Moore J, Babidge W . Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci. 1997; 42(8):1571-9. DOI: 10.1023/a:1018851723920. View

2.
Windey K, De Preter V, Verbeke K . Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2011; 56(1):184-96. DOI: 10.1002/mnfr.201100542. View

3.
Severance E, Yolken R, Eaton W . Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 2014; 176(1):23-35. PMC: 4294997. DOI: 10.1016/j.schres.2014.06.027. View

4.
Leiva-Gea I, Sanchez-Alcoholado L, Martin-Tejedor B, Castellano-Castillo D, Moreno-Indias I, Urda-Cardona A . Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study. Diabetes Care. 2018; 41(11):2385-2395. DOI: 10.2337/dc18-0253. View

5.
Tsoi H, Chu E, Zhang X, Sheng J, Nakatsu G, Ng S . Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 2017; 152(6):1419-1433.e5. DOI: 10.1053/j.gastro.2017.01.009. View